West Pharmaceutical Services (WST) Receivables - Other (2017 - 2025)
Historic Receivables - Other for West Pharmaceutical Services (WST) over the last 9 years, with Q3 2025 value amounting to $27.5 million.
- West Pharmaceutical Services' Receivables - Other fell 3498.82% to $27.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 3498.82%. This contributed to the annual value of $23.3 million for FY2024, which is 837.21% up from last year.
- As of Q3 2025, West Pharmaceutical Services' Receivables - Other stood at $27.5 million, which was down 3498.82% from $27.9 million recorded in Q2 2025.
- Over the past 5 years, West Pharmaceutical Services' Receivables - Other peaked at $42.3 million during Q3 2024, and registered a low of $10.1 million during Q2 2021.
- Over the past 5 years, West Pharmaceutical Services' median Receivables - Other value was $19.9 million (recorded in 2023), while the average stood at $20.3 million.
- Per our database at Business Quant, West Pharmaceutical Services' Receivables - Other crashed by 3988.1% in 2021 and then soared by 11256.28% in 2024.
- Over the past 5 years, West Pharmaceutical Services' Receivables - Other (Quarter) stood at $14.6 million in 2021, then grew by 11.64% to $16.3 million in 2022, then surged by 31.9% to $21.5 million in 2023, then grew by 8.37% to $23.3 million in 2024, then rose by 18.03% to $27.5 million in 2025.
- Its last three reported values are $27.5 million in Q3 2025, $27.9 million for Q2 2025, and $25.8 million during Q1 2025.